Your browser doesn't support javascript.
loading
Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis.
Khanna, Vishesh; Azenkot, Tali; Liu, Selina Qiuying; Gilbert, Jason; Cheung, Edna; Lau, Kimberly; Pollyea, Daniel A; Traer, Elie; Jonas, Brian A; Zhang, Tian Y; Mannis, Gabriel N.
Afiliación
  • Khanna V; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA.
  • Azenkot T; Department of Medicine, University of California Davis School of Medicine, Sacramento, CA, USA.
  • Liu SQ; Knight Cancer Institute, Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR, USA.
  • Gilbert J; Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Cheung E; Department of Pharmacy, Stanford Healthcare, Stanford, CA, USA.
  • Lau K; Department of Pharmacy, Stanford Healthcare, Stanford, CA, USA.
  • Pollyea DA; Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Traer E; Knight Cancer Institute, Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR, USA.
  • Jonas BA; Department of Medicine, Division of Malignant Hematology, Cellular Therapy and Transplantation, University of California Davis School of Medicine, Sacramento, CA, USA.
  • Zhang TY; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA.
  • Mannis GN; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: gmannis@stanford.edu.
Leuk Res ; 131: 107331, 2023 08.
Article en En | MEDLINE | ID: mdl-37263072
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Antineoplásicos Tipo de estudio: Clinical_trials / Risk_factors_studies Idioma: En Revista: Leuk Res Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Antineoplásicos Tipo de estudio: Clinical_trials / Risk_factors_studies Idioma: En Revista: Leuk Res Año: 2023 Tipo del documento: Article